19 reports

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • Baltics
  • Latin America
  • Demand

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Australasia
  • Baltics
  • Demand
  • Forecast

2018 Europe Diagnostics Market Forecasts 2018 Europe Diagnostics Market Forecasts for ## Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular

  • Cancer Diagnostics
  • Diagnostics
  • Baltics
  • Forecast
  • Market Size

2019 Europe Diagnostics Market Forecasts for ## Tests 2019 Europe Diagnostics Market Forecasts for ## Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Mo

  • Cancer Diagnostics
  • Diagnostics
  • Baltics
  • Forecast
  • Market Size

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Baltics
  • Demand
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Baltics

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Diagnostics
  • Medical Biotechnology
  • Baltics
  • North America
  • World

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Australasia
  • Baltics
  • Demand

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Baltics
  • Northern Europe
  • Demand

Contains ##, ## pages and ## tables Companies Profiled Competitive Assessments - Abbott - Beckman Coulter/ Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio - Grifols - Hologic - Immucor - LabCorp - Ortho-Clinical Diagnostics - Proteome Science

  • Diagnostics
  • Infectious Disease
  • Pathology
  • Baltics
  • Demand

Instrumentation Review - Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

  • Cancer Diagnostics
  • Diagnostics
  • Medical Biotechnology
  • Baltics
  • Northern Europe

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Baltics
  • Scandinavia
  • Demand

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Diagnostics
  • Medical Biotechnology
  • Baltics
  • Northern Europe
  • Demand

Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

  • Diagnostics
  • APAC
  • Australasia
  • Baltics
  • North America

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Baltics

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Baltics
  • Demand
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Baltics
  • Northern Europe

Contains ## pages and ## tables Companies Profiled Competitive Assessments - Abbott - Beckman Coulter/ Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio - Grifols - Hologic - Immucor - LabCorp - Ortho-Clinical Diagnostics - Proteome Sciences

  • Diagnostics
  • Infectious Disease
  • Baltics
  • Demand
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Baltics